Cancer astrocytes have a more conserved molecular status in long recurrence free survival (RFS) IDH1 wild-type glioblastoma patients: new emerging cancer players.
Franceschi S, Lessi F, Aretini P, Ortenzi V, Scatena C, Menicagli M, La Ferla M, Civita P, Zavaglia K, Scopelliti C, Apollo A, Carbone FG, Vannozzi R, Bevilacqua G, Pasqualetti F, Naccarato AG, Mazzanti CM.
Franceschi S, et al. Among authors: naccarato ag.
Oncotarget. 2018 May 8;9(35):24014-24027. doi: 10.18632/oncotarget.25265. eCollection 2018 May 8.
Oncotarget. 2018.
PMID: 29844869
Free PMC article.